We investigated whether treatment with PU-91 (P), quercetin (Q), or in combination (P+Q) would increase/decrease the expression of CDKN1A and LMNB1 in NL, AMD, KC, and Glc cybrids. The gene discussed is CDKN1A; the disease is age-related macular degeneration.